Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
LEXINGTON, Massachusetts, August 3 /PRNewswire-FirstCall/ -- Shire plc
(LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company,
today reported positive results from the first of three Phase III studies of
velaglucerase alfa, its enzyme replacement therapy in development fo...
MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up
EVEREST High-Risk Registry Data Shows Improved Symptomatic Status and Cardiac Function in Functional MR Patients Treated with the MitraClip(R) System
ORLANDO, Fla., March 28 /PRNewswire/ -- Percutaneous mitral valve repair using the MitraClip(R) system in symptomatic high-risk surgical patien...
New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide
Dr. Zeda Rosenberg, CEO of the International Partnership for Microbicides, issued the following statement on the results of the Phase II/IIb safety and effectiveness study of BufferGel and PRO2000 (0.5 percent concentration):
SILVER SPRING, Md., Feb. 9 /PRNewswire/ -- The Microbicide Trials N...
New Research Suggests Platelet 'Stickiness' May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease
BALTIMORE, Jan. 27 /PRNewswire/ -- Most Americans know their cholesterol level, but do they know how "sticky" their platelets are? Research findings from Dr. Paul A. Gurbel, an interventional cardiologist and Director of the Sinai Center for Thrombosis Research based at Sinai Hospital of Baltimor...
Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
Genetic Variations Identify Predisposition to More Severe Knee Osteoarthritis
WALTHAM, Mass., Sept. 15 /PRNewswire-FirstCall/ -- Interleukin
Genetics, Inc. (Amex: ILI ), announced today that Kenneth Kornman, Ph.D.,
the company's Chief Scientific Officer, will ...
New Research on Pre-Eclampsia in Mice May Have Important Implications for Humans
Team Supported by March of Dimes Publishes Findings in Nature Medicine
WHITE PLAINS, N.Y., July 28 /PRNewswire-USNewswire/ -- In a new March
of Dimes-funded study of pre-eclampsia, a serious and potentially deadly
disorder that affects about 5 percent of pregnancies, researchers have
Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel
Company's End-of-Phase II Meeting with FDA Set for Sept. 29
LA JOLLA, Calif., June 30 /PRNewswire/ -- TorreyPines Therapeutics,
Inc. (Nasdaq: TPTX ) today announced that data presented at the 50th Annual
Scientific Meeting of the American Headache Society showed that, in
addition to mee...
Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimer's Therapeutic Antibody
NEW YORK, June 24 /PRNewswire-FirstCall/ -- Intellect Neurosciences,
Inc. (OTC Bulletin Board: ILNS) and MRC Technology (MRCT) announced today
they have achieved an important
milestone through their collaborative
efforts to humanize Intellect's lead antibody IN-N01 necessary for creating
Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
Results Suggested Improvements in Several Endpoints for Advair Diskus(R) Compared to ICS Alone
RESEARCH TRIANGLE PARK, N.C., June 10 /PRNewswire/ -- African American
patients with asthma treated with Advair Diskus, a combination of the
long-acting beta-agonist (LABA) sa...
Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R)
SAN FRANCISCO, June 9 /PRNewswire/ -- Two long-term, large-scale and
independent studies evaluating cardiovascular (CV) outcomes in people with
type 2 diabetes enrolled more than 9,300 patients taking AVANDIA(R)
(rosiglitazone maleate) and provide more than 20,000 patient years of
MultiVu Video Feed: Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA
NEW YORK, June 9 /PRNewswire/ --
Monday, June 9th, 2008 1:00 PM - 1:15 PM ET Galaxy 26 Transponder 24 C-Band Downlink Freq: 4180 H
NEWS: LARGE, LONG-TERM VETERANS AFFAIRS DIABETES TRIAL (VADT) REVEALS IMPORTANT
CARDIOVASCULAR SAFETY NEWS ON AVANDIA
Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R)
Primary Findings from VADT on Benefit of Intensive Blood Sugar Control Are
Not Statistically Significant but Show Favorable Trend in Reducing Most CV Events
SAN FRANCISCO, June 8 /PRNewswire/ -- Findings from the Veterans
Affairs Diabetes Trial (VADT), a large, ...
Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
Retrospective Chart Review in 10 Geographic Regions throughout the United
States Presented at Pediatric Academic Societies (PAS) Annual Meeting
HONOLULU, May 5 /PRNewswire/ -- MedImmune announced today that the
company presented results from a retrospective chart review that evaluated
Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
- Second research program centered on potential target in inflammatory indications such as rheumatoid arthritis -
NUTLEY, N.J., April 15 /PRNewswire/ -- Roche announced today that it
will acquire Piramed Limited, a privately-owned UK company focusing on
therapeutics targeting PI...
ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
FREDERICK, Md., April 8, 2008 /PRNewswire/ -- ImQuest scientists Robert
W. Buckheit, Jr., Ph.D. and Karen M. Watson, M.S. presented the results of
studies performed with products licensed by ImQuest Life Sciences, Inc. at
the recent Microbicides 2008, an international conference held in New
Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
Model Created Using Piecewise Smooth Subdivision Surface Provides Both Shape and Volumetric Evaluation of Tetralogy of Fallot Patients
SEATTLE, April 8, 2008 /PRNewswire/ -- Three dimensional visualization
of the right ventricle provides important
shape and volumetric insights
that help ca...
ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
FREDERICK, Md., April 1, 2008 /PRNewswire/ -- ImQuest BioSciences, Inc.
announced today the publication of the results of an important
activity relationship study to investigate the efficacy and toxicity of a
series of pyrimidinedione analogs against HIV-1 and HIV-2. The manuscript,...
Six Important Things to Know About Preventing Hospital Infections
Infection Control Professional Offers Patient Tips to Guard Against
KANSAS CITY, Kan., April 02, 2007 /PRNewswire/ -- Hospital
infections are among the top ten leading causes of death in the
United States, according to the Centers for Disease Control. There
are countless storie...
Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role
Regulating the Oxidative Damage Induced by Ionizing Radiation
LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Apr 23, 2007 - Aeolus
Pharmaceuticals, Inc. (OTCBB:AOLS) announced the presentation of
data by researchers at Loma Linda University Medical Center showing
that one of the Company's metalloporphyrin antioxidants, AEOL
10113, may play an important
Landmark Study Published in the New England Journal of Medicine
Shows Important Benefits of Eprodisate (KIACTA) Treatment for
Patients with Amyloid A (AA) Amyloidosis
ECUBLENS, SWITZERLAND, June 07, 2007 /PRNewswire-FirstCall/ -
Neurochem (International) Limited (Neurochem), a wholly-owned
subsidiary of Neurochem Inc. , announces that the New England
Journal of Medicine (NEJM) published the results of the "Eprodisate
For AA Amyloidosis Trial" (EFAAT), recognize...
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure
Reduction During Important Early Morning Period When Most Adverse
Cardiovascular Events Occur
- Blood pressure reduction achieved at 8 am versus placebo: - 25
/ - 13 mm Hg (systolic / diastolic, p
- Blood pressure reduction dependent on vaccine dose and induced
antiangiotensin II antibody levels
- Detailed results presented today at the Seventeenth European
Meeting on Hypertension in Mil...
New Report 'Looking at Chiral Technologies' Analyzes the Global
Market Growth Forecasts Driven By Two Very Important Components as
Single Isomer Drugs and Single Enantiomer Pharmaceuticals
DUBLIN, Ireland--(BUSINESS WIRE)--Jun 21, 2007 - Research and
Markets (http://www.researchandmarkets.com/reports/c60415) has
announced the addition of Looking at Chiral Technologies to their
The advancements in molecular research and continued untiring
efforts of the research industry to...
Regular Yoga Practice Is Associated With Mindful Eating
...naire overall (and on each of the categories within the questionnaire) was associated with a lower BMI, which suggests that mindful eating may play an important
role in long-term weight maintenance, Kristal said.
"Mindful eating is a skill that augments the usual approaches to weight loss, such as dieti...
Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
...e Officer of Sanofi Pasteur. "It is essential that we pursue the vaccine licensure pathway made available to us, while at the same time, continue the important
clinical studies of our vaccine."
The supplemental application follows recent recommendations by the FDA to evaluate the influenza A(H1N1) 200...
Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
"We believe that these data document an important
advance for patients with metastatic colorectal ca...st twenty-five years indicate that KRAS plays an important
role in cell growth regulation. In mCRC, EGFR tran...ons in the rest of the world are pending.
Product Safety Information
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...the same periods in 2008.
"During the last quarter, we and Genzyme made great progress regarding mipomersen on two important
fronts, advancing the clinical development program and refining our regulatory strategy. We reported positive top-line results from a Phase 3 study o...
Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
...oliferation and differentiation in developing tissues and appear to play an important
role in regulating bone remodeling in adults. While both peptides have demo... without loss of functionality or impairment of safety and tolerability, an important
convenience advantage for patients that would eliminate the refrigeration r...
NewCardio Announces Master Services Agreement With Dedicated Phase I
...d CEO of Dedicated Phase I, commented, "We are excited to add NewCardio's QTinno(TM) solution to our advanced Core ECG laboratory. By integrating this important
technological advancement with our existing solutions, we can deliver TQT/QTc studies for upload to the FDA digital ECG warehouse with greater accurac...
NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
...lity influenza vaccine within 12 weeks under real pandemic conditions is an important
and successful test of our VLP technology. With further scale up, recombin...e release. We are proud of our staff who worked tirelessly to achieve this important
milestone while working concurrently to produce materials for a clinical st...
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
...bit penetration across the blood-brain barrier, an important
potential advance for small molecule therapies. Th...re in obtaining regulatory approval in one or more important
markets; (iii) the company's patent applications f...cularly if unanticipated; and (vii) certain other important
risks and uncertainties set forth in the company's...
Study Shows Brain Fitness can Save Medicare Billions
...the groups were statistically significant and only the group using the Posit Science(R) software showed significant savings.
"Our results have important
health policy relevance," said Frederic Wolinsky, PhD, of the University of Iowa who was lead author on the article. "The reduced costs were equal to ...
Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
...y developing a new therapy," said
Rolland-Yves Mauvernay, President and Founder of Debiopharm Group."
"This alliance with Debiopharm represents important
Mercury's technology and of the growing appreciation of AMPK as a novel drug
target for metabolic diseases. The development of an orally...
TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men
...erventions to slow the aging process and improve health outcomes for older persons. In addition, KLRI helps the medical and lay communities understand important
aging issues. KLRI research findings support a healthier quality of life and a robust lifestyle in our senior years. For more information, visit www...
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
...nce and can also help many patients delay the time to relapse."
Visit http://www.INVEGASUSTENNA.com for full prescribing information.
SAFETY INFORMATION FOR INVEGA ((R)) SUSTENNA(TM)
INVEGA ((R)) SUSTENNA(TM) is not approved for the treatment of dementia-related psycho...
Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
...enerated more than $3 billion in revenue globally in 2008. Access believes that ProLindac, as a well-tolerated and active DACH platinum, represents a important
improvement in the design and tolerability of platinum chemotherapies.
Later this month, an Access management and clinical development team is ...
British Woman Celebrates a Year of Living Cancer-Free
...is said. "However, this is a Phase I study that has been designed to assess toxicity as the main end point, efficacy being a secondary one. It is very important
for us to be able to recruit more patients and complete the current phase before moving to a multicenter international study demonstrating favorable c...
Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window
... beyond eight hours of symptom onset has traditionally been the single most important
factor in excluding patients from stroke treatment. Thus, continued Noguei...d evidence of salvageable brain tissue in the area of the stroke, it was an important
avenue to pursue. This meant that endovascular therapy (performed by neuro...
FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia
...lerability or incomplete efficacy. Metabolic safety, including weight gain, elevation of lipid levels (dyslipidemia) and glucose dysregulation, is an important
consideration with any antipsychotic treatment. Patients often need to switch treatments in order for physicians to balance effective treatment with ...
VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
...itro and in vivo readouts becoming increasingly important
in research today, and we are extremely pleased th...h team answer some of the key questions about this important
biologic pathway in vivo ," said Dr. Jeffrey Pete...cyte activity in vivo . These results enabled an important
data correlation that further enhanced the integra...
Is Your Hair Taking a Break?
...ion, both in terms of how people see their own hair loss and how physicians who are not dermatologists approach hair loss," said Dr. McMichael. "It is important
for women to be evaluated by a dermatologist, who specializes in hair loss, at the first signs of a problem -- whether she notices that her ponytail i...